about
Fetal safety profile of aromatase inhibitors: Animal data.Proteome analysis of human follicular fluid.Plasma concentrations of D-dimer and outcome of in vitro fertilization.mTrop1/Epcam knockout mice develop congenital tufting enteropathy through dysregulation of intestinal E-cadherin/β-catenin.Corifollitropin alfa compared to daily FSH in controlled ovarian stimulation for in vitro fertilization: a meta-analysisTeratological consequences of nitric oxide synthesis inhibition.Assisted reproduction outcomes after embryo transfers requiring a malleable styletReducing the trigger dose of recombinant hCG in high-responder patients attending an assisted reproductive technology program: an observational study.The role of toxicology to characterize biomarkers for agrochemicals with potential endocrine activities.Molecular aspects of azoles-induced teratogenesis.Hormonal and reproductive disturbances in epileptic male patients: emerging issues.Extrapituitary actions of GnRH antagonists: prospects for in vitro fertilization programs.Nitric oxide and teratogenesis: an update.Developmental neurotoxicity and anticonvulsant drugs: a possible link.Ovotoxicity of cigarette smoke: A systematic review of the literature.Teratology of valproic acid: an updated review of the possible mediating mechanisms.Aspirin pretreatment potentiates hyperthermia-induced teratogenesis in the mouse.Mole modifications following controlled ovarian stimulation for assisted reproduction technologies.Transplacental exposure to methylene blue initiates teratogenesis in the mouse: preliminary evidence for a mechanistic implication of cyclic GMP pathway disruption.Additional investigation on the potentiation of phenytoin teratogenicity by fluconazole.Aromatase inhibitors and teratogenesis.Influence of cigarette smoking on vitamin E, vitamin A, beta-carotene and lycopene concentrations in human pre-ovulatory follicular fluid.Impact of estrogen replacement on letrozole-induced embryopathic effects.Effects of the aromatase inhibitor letrozole on in utero development in rats.Pharmacological developments in assisted reproduction.Murine teratology of fluconazole: evaluation of developmental phase specificity and dose dependence.Increased rounds of gonadotropin stimulation have side effects on mouse fallopian tubes and oocytes.Cigarette smoke is associated with altered expression of antioxidant enzymes in granulosa cells from women undergoing in vitro fertilization.Prevention of valproic acid-induced neural tube defects by sildenafil citrate.Clinical experience with an ovarian stimulation protocol for intrauterine insemination adopting a gonadotropin releasing hormone antagonist at low dose.Folate serum levels in Italian women entering an in vitro fertilization program.Association study of AMH and AMHRII polymorphisms with unexplained infertility.Defining critical periods for itraconazole-induced cleft palate, limb defects and axial skeletal malformations in the mouse.Spatial distribution of glutathione, glutathione-related and antioxidant enzymes in cultured mouse embryos.Prevalence of chromosomal abnormalities in 2078 infertile couples referred for assisted reproductive techniquesPurification and characterization of three pi class glutathione transferase from monkey (Macaca fascicularis) placentaVEGFR2 Expression Is Differently Modulated by Parity and Nulliparity in Mouse OvaryScreening of mutations in the CFTR gene in 1195 couples entering assisted reproduction technique programsMorphometric and ultrastructural analysis of human granulosa cells after gonadotrophin-releasing hormone agonist or antagonistPotential involvement of yolk sac in teratogenesis
P50
Q31134494-5A916448-13D2-4297-9E5B-EF694C38545DQ33261692-8276CA01-C747-4A04-B7E3-D97605130DF8Q33726280-1DD5211B-F17A-409C-9D94-546A7CF46582Q34499625-8846EFF0-E3E7-46A1-AAC2-D340DB7ED3A2Q35735337-3CBCC2C9-3A41-42A7-BED2-B79F863368CEQ35867198-5117F991-1702-480E-BBC7-55A50131BF78Q36106442-DCDB0DC0-B4D3-4ADD-BCF8-01E5B6D927C8Q36926487-C69FFFC2-3CEA-40B9-9E9C-EA154F645C26Q37214118-486C9D99-88B7-46C7-A907-D00404CAC947Q37681552-F98E2FAB-1485-4E1A-AE84-49CAD7240393Q37845482-4550B232-0465-4304-8276-4E5041300461Q37974264-834E618D-5D38-4DFC-99FF-AAFD629BADCAQ38185723-BBA224F8-8DA3-44D4-A930-2CEF21FD355AQ38209905-5EB9824B-14BF-4A55-9F71-0CCA8ED00F9DQ38690442-76197139-BFEC-4C0B-8648-037FDCAB9817Q38842816-71207DD8-A5FE-4BD6-A899-0A3BF699CB72Q40641003-CDD1BAD4-B924-4C6B-919A-E51F7F48D5ECQ41066152-105A37F7-6E68-4B46-B7E4-2EB924489244Q43765142-102F95A1-6F57-4809-A96A-4AD31064F858Q44633449-BC815919-825A-414B-B56E-19F476E58D93Q44831926-F54909AF-CCD0-4426-A2C6-ECF04C8667DFQ45088427-E9A7A89A-C8F6-488F-89C3-836B6033F772Q45917481-4990D26E-7AA6-4352-B815-70ABEB4F625EQ46336436-D3723C87-96EF-4155-AFA4-2B91757E847FQ46426197-35596CEF-3BD4-4A18-B322-0BD19B103D09Q46497275-0F4C8604-6335-493A-BC30-90EE7C3C2043Q47231223-62FEBBAC-33DD-4D4D-934A-2AB6D25242B7Q48518629-A563B52E-3A19-4E06-8CEA-D7F10720DEA8Q50595255-E61CE686-55DD-421E-BD7D-5CBD40A343B1Q51283484-B93E61B3-F73A-4D0C-B47C-1648A7465530Q51808702-F2120929-208B-42B9-8430-7EB07BF5BDBEQ51824421-9A6B7EA9-7366-45F7-81BE-780892DAF549Q52006509-4DAF9C15-283A-47E1-B45B-7F6C28145345Q52197092-8A888321-70AA-4F0A-8F92-685775D4ADF4Q57000485-C8014907-DCB7-4408-BE67-B9A99C869F93Q57081185-2BE2AD63-033C-4AD8-BAE0-ECD703230A89Q57493351-A320B085-D0D5-4AC0-B06E-F0FF8C6D14F6Q58193710-C71182D9-799B-40FF-8BC4-F7F899871574Q59592720-DB54AF2E-A82E-40CF-8CE1-66A36B0E6A84Q71335781-62B82C5D-4A72-443C-B07F-08776A22A487
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Gian Mario Tiboni
@ast
Gian Mario Tiboni
@en
Gian Mario Tiboni
@es
Gian Mario Tiboni
@nl
type
label
Gian Mario Tiboni
@ast
Gian Mario Tiboni
@en
Gian Mario Tiboni
@es
Gian Mario Tiboni
@nl
prefLabel
Gian Mario Tiboni
@ast
Gian Mario Tiboni
@en
Gian Mario Tiboni
@es
Gian Mario Tiboni
@nl
P106
P1153
7003671250
P31
P496
0000-0002-3030-5230